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Heterochromatin underpins gene repression, genome integrity, and chromosome segregation. In the fission yeast Schizosaccha-
romyces pombe, conserved protein complexes effect heterochromatin formation via RNA interference-mediated recruitment of a
histone H3 lysine 9 methyltransferase to cognate chromatin regions. To identify small molecules that inhibit heterochromatin
formation, we performed an in vivo screen for loss of silencing of a dominant selectable kanMX reporter gene embedded within
fission yeast centromeric heterochromatin. Two structurally unrelated compounds, HMS-I1 and HMS-I2, alleviated kanMX si-
lencing and decreased repressive H3K9methylation levels at the transgene. The decrease in methylation caused by HMS-I1 and
HMS-I2 was observed at all loci regulated by histone methylation, including centromeric repeats, telomeric regions, and the
mating-type locus, consistent with inhibition of the histone deacetylases (HDACs) Clr3 and/or Sir2. Chemical-genetic epistasis
and expression profiles revealed that both compounds affect the activity of the Clr3-containing Snf2/HDAC repressor complex
(SHREC). In vitroHDAC assays revealed that HMS-I1 and HMS-I2 inhibit Clr3 HDAC activity. HMS-I1 also alleviated trans-
gene reporter silencing by heterochromatin in Arabidopsis and a mouse cell line, suggesting a conserved mechanism of action.
HMS-I1 and HMS-I2 bear no resemblance to known inhibitors of chromatin-based activities and thus represent novel chemical
probes for heterochromatin formation and function.
Specialized chromatin domains termed heterochromatin areimportant for mediating dosage compensation, monoallelic
imprinting, and cell lineage-specific gene expression. Large het-
erochromatin domains are associated with arrays of repetitive el-
ements found at centromeres in many eukaryotes (1). Such het-
erochromatic regions inmost genomes tend to be devoid of genes,
and the transcription of genes placed within heterochromatin is
inhibited because the resident repetitive elements attract chroma-
tin-modifying activities that repress transcription (2, 3). Tran-
scriptionally repressive modifications such as H3K9 methylation
(H3K9me) are prevalent in heterochromatic regions, whereas
activating modifications, such as histone acetylation, are scarce
(4, 5). H3K9 methylation allows the binding of specific chro-
modomain proteins, including HP1 (heterochromatin protein
1), which recruit a variety of key chromatin-modifying activities
(6–8). Heterochromatin formation on repetitive elements renders
these regions transcriptionally inert and promotes genome stabil-
ity through the regulation of recombination, DNA repair, and
chromosome segregation (3). In fungi, plants, and animals, the
integrity of heterochromatin can bemonitored by the use of tran-
scriptionally silent reporter genes placedwithin or close to centro-
meric repeats or elsewhere (9–11).
In the fission yeast Schizosaccharomyces pombe, heterochroma-
tin is found at centromeres, telomeres, and the silent mating-type
locus. Many of the key components involved in forming hetero-
chromatin are conserved in multicellular eukaryotes (12). Clr4
methyltransferase is the fission yeast counterpart of metazoan
Suv39; the enzyme methylates histone H3 specifically on lysine 9
(H3K9me) (4, 13).H3K9methylation creates a binding site for the
chromodomain proteins Swi6 and Chp2, which are the orthologs
of metazoan HP1 (6, 7, 14). RNA interference (RNAi) utilizes the
conserved core activities of Dicer (Dcr1), Argonaute (Ago1), and
RNA-dependent RNA polymerase (Rdp1) to direct Clr4 methyl-
transferase to specific chromatin regions in fission yeast (12). The
binding of Swi6 and Chp2 to H3K9me results in the recruitment
of the Snf2/histone deacetylase (HDAC) repressor complex
(SHREC) to complete heterochromatin formation and transcrip-
Received 2 September 2014 Returned for modification 25 September 2014
Accepted 28 November 2014
Accepted manuscript posted online 8 December 2014
Citation Castonguay E, White SA, Kagansky A, St-Cyr DJ, Castillo AG, Brugger C,
White R, Bonilla C, Spitzer M, Earnshaw WC, Schalch T, Ekwall K, Tyers M, Allshire
RC. 2015. Panspecies small-molecule disruptors of heterochromatin-mediated
transcriptional gene silencing. Mol Cell Biol 35:662–674.
doi:10.1128/MCB.01102-14.
Address correspondence to Mike Tyers, md.tyers@umontreal.ca, or Robin C.
Allshire, robin.allshire@ed.ac.uk.
* Present address: Rachel White, Edinburgh Cancer Research Centre, MRC Institute
of Genetics and Molecular Medicine, The University of Edinburgh, Edinburgh,
United Kingdom; Carolina Bonilla, Department of Biosciences and Nutrition,
Karolinska Institutet, Solna, Sweden; Michaela Spitzer, Department of Biochemistry
and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Supplemental material for this article may be found at http://dx.doi.org/10.1128
/MCB.01102-14.
Copyright © 2015 Castonguay et al. This is an open-access article distributed
under the terms of the Creative Commons Attribution 3.0 Unported license.
doi:10.1128/MCB.01102-14
662 mcb.asm.org February 2015 Volume 35 Number 4Molecular and Cellular Biology
 o
n
 M
arch 2, 2015 by UNIVERSITY O
F EDINBURG
H
http://m
cb.asm
.org/
D
ow
nloaded from
 
tional silencing (15, 16). SHREC consists of the HDAC Clr3, the
SNF2-related chromatin remodeling factorMit1, and two nonen-
zymatic components, Clr1 and Clr2 (15). The HDACs Clr6 and
Sir2 also facilitate removal of histone acetylation to maintain het-
erochromatin integrity (17–19). SHREC resembles the vertebrate
Mi-2/NuRD silencing complex, which contains HDAC1/2 and
SNF2 ATPase Mi-2, among other proteins (20), although it re-
mains unclear whether RNAi directly modulates chromatinmod-
ification inmammals (1). Related protein complexes are known to
couple RNAi to DNA methylation, H3K9 methylation, and gene
silencing in plants (21, 22). In Arabidopsis, RNAi also contributes
to heterochromatin integrity by directing de novo DNA methyl-
ation to homologous sequences (23, 24), where it recruits Suv39
methyltransferase related proteins (25).
RNAi and heterochromatin components are not essential for
viability of fission yeast. This has facilitatedmechanistic dissection
of the process initially through genetic screens and subsequently
viamass spectrometric analysis of purified protein complexes (10,
15, 26–29). Deletion of individual RNAi or heterochromatin
components disrupts silencing of reporter genes inserted
within heterochromatin (10, 15, 28, 30). Small-molecule inhib-
itors provide an alternative means for probing biological path-
ways. In contrast to mutations, inhibitor effects are usually
reversible and thereby enable precise determination of func-
tional dependencies in complex pathways (31–33). For exam-
ple, in vivo screens based on telomere position effect in bud-
ding yeast have previously allowed the identification of sirtinol
and splitomicin, which inhibit Sir2 (34, 35). Fission yeast is
amenable to high throughput cell-based screens (36–38) and
the integrity of its heterochromatin and associated gene silenc-
ing have been shown to be sensitive to the HDAC inhibitor trichos-
tatin A (TSA) (39, 40). Unbiased small-molecule screens may thus
identify novel compounds that inhibit the function of components
of the RNAi-directed chromatin modification system in fission
yeast, such as Dicer, Argonaute, Clr4 H3 lysine 9 methyltrans-
ferase and the variousHDACs. Because small molecules identified
from yeast screens may also inhibit conserved orthologs (41–44),
inhibitors of fission yeast heterochromatin integrity may yield in-
sights into related processes in higher eukaryotes, including hu-
mans. Small-molecule inhibitors of heterochromatin may be of
therapeutic value in cancer and other diseases caused by aberrant
gene regulation. For example, the HDAC inhibitors vorinostat
and romidepsin, as well as the histone lysine methyltransferase
inhibitor chaetocin, have antitumorigenic activity (45, 46).
We report here a cell-based screen for small-molecule inhibi-
tors of fission yeast heterochromatin. Two novel compounds,
called HMS-I1 and HMS-I2, were identified that disrupt hetero-
chromatin integrity at the level of the SHREC complex. HMS-I1
also disrupts transgene silencing in the plant Arabidopsis thaliana
and in mammalian cells. Both compounds appear to exert their
effect on heterochromatin integrity through inhibition of class II
HDACs. This screen in fission yeast has thus identified novel small
molecules that interfere with heterochromatin integrity across the
fungal, plant, and animal kingdoms.
MATERIALS AND METHODS
Fission yeast growth and chemical screens.Haploid Schizosaccharomyces
pombe cells were grown in YES (yeast extract with supplements) medium
at 32°C and assessed in log phase for all experiments. Cells and com-
pounds were dispensed in 96-well microplates using a Biomek FX liquid
handling robot (Beckman Coulter) and plates were read (optical density
at 595 nm [OD595]) every 15 min for 48 to 72 h at 32°C with continuous
shaking in a Sunrise plate reader (Tecan). Growth curves generated for
each compound were analyzed using in-house R scripts and the grofit R
package to extract parameters for doubling time, lag time and saturation
time. Table 1 contains a list of the strains used in the present study.
Characterization of chemical compounds. 1H and 13C NMR, re-
corded at 400 and 100 MHz, respectively, were performed on a Varian
400-MR spectrometer. Assignments of 1H and 13C NMR signals were
carried out by correlation spectroscopy (COSY) andHeteronuclear Single
QuantumCoherence (HSQC) experiments.Mass spectral (MS) and high-
resolution mass spectrometry (HRMS) data were recorded on Agilent
6120 Quadrupole LC/MS and Agilent LC/MSD TOF (model 61969A)
systems, respectively.
The data obtained for compound 2-(2,3-dihydrobenzo[b][1,4]dioxin-
6-yl)-6-methylimidazo[1,2-a]pyridine (HMS-I1) were as follows: (i) 1H
NMR (400 MHz, CDCl3):  (ppm) 7.87 (s, 1H, MeCCHN), 7.66 (s, 1H,
NCHC), 7.50 (d, J  9.00 Hz, 1H, N2CCH), 7.41 to 7.47 (m, 2H, o-
CHCC), 6.99 (dd, J 1.17, 9.39 Hz, 1H,MeCCHC), 6.92 (d, J 7.83 Hz,
1H, p-OCCH), 4.30 (s, 4H, OCH2), 2.31 (s, 3H, CH3); (ii)
13C NMR (100
MHz, CDCl3):  (ppm) 145.4, 144.8, 143.9, 143.6, 127.8, 127.7, 123.4,
122.0, 119.4, 117.6, 116.8, 115.0, 107.3, 64.6, 64.5, 18.2; (iii) 13C NMR
(100 MHz, CDCl3, CH(1/3 or 2) from HSQC):  (ppm) 127.7 (MeCCHC),
123.4 (MeCCHN), 119.4 (p-OCCCH), 117.7 (p-OCCH), 116.8
(N2CCH), 115.1 (m-OCCH), 107.3 (NCHC), 64.5 (OCH2), 18.2 (CH3);
(iv) HRMS (ESI-TOF) m/z: [M  H] calculated for C16H15N2O2
267.1128; found 267.1137.
The data obtained for compound N-(benzo[b]thiophen-2-yl)-4-(2-
chloro-6-fluorobenzyl)piperazine-1-carboxamide (HMS-I2) were as fol-
lows: (i) 1H NMR (400MHz, CDCl3):  (ppm) 7.72 (d, J 7.92 Hz, 1H),
7.55 (d, J 7.63Hz, 1H), 7.13 to 7.32 (m, 4H), 6.96 to 7.06 (m, 2H, ArCH,
NH), 6.73 (s, 1H), 3.76 (d, J 2.35 Hz, 2H, CH2Ar), 3.45 to 3.59 (m, 4H,
CH2NCO), 2.59 to 2.66 (m, 4H, CH2NCC); (ii)
13C NMR (100 MHz,
CDCl3, CH(1/3 or 2) fromHSQC):  (ppm) 129.4 (CH), 125.6 (CH), 124.3
(CH), 122.4 (CH), 121.8 (CH), 121.5 (CH), 114.0 (CH), 105.2 (CH), 52.3
(CH2Ar), 52.28 (CH2NCC), 44.2 (CH2NCO); (iii) LC-MS (APCI) m/z:
[MH] calculated for C20H20ClFN3OS 404.1; found 404.1.
TABLE 1 Fission yeast strains used in this study
Strain Genotype
1056 mat1::ura4 ade6-210 leu1-32 ura4
5962 h clr3::kanMX ade6-210 ura4-D18 leu1-32
8878 h sir2::NatMX ade6-210 leu1-32 arg3-D4 his3-D ura4-D18
9299 h90 mat3::ura4 ura4-DS/E dcr1D::NAT
9351 h sir2::NatMX his3D arg3-D4 leu1-32 ade6-210 ura4-D18
17425 h dcr1::KanMX otr1R(SphI):ade6 ade6-210 leu1-32 ura4-D18
17668 h dcr1::KanMX sir2::NatMX ade6-210 leu1-32 ura4-D18
17860 h90 dcr1::KanMX sir2::NatMX ade6-210 leu1-32 ura4-D18
his3-D1
18618 h? clr3::KanMX sir2::NatMX ade6-704–HygMX6 leu1-32
ura4-D18
19650 Mat1-MsmtO leu1-32 ade6-210 his2 ura4-DS/E clr3-3FLAG-
KanMX otr1R(SphI)::ura4
20079 h ade6-210 leu1-32 ura4-D18 imr1R (dg-glu) NcoI::kanMX
oriII
20080 h (XbaI-SpeI)clr4::LEU2 ade6-210 leu1-32 ura4-D18 imr1R
(dg-glu) NcoI::kanMX oriII
20303 h clr2::his7 ade6-216 ura4-D18 his7-366 leu1-32
20304 h clr2::kanMX ade6-210/216 ura4-D18 leu1-32
20305 hmit1::kanMX ade6-210 ura4-D18 leu1-32
20306 hmit1::kanMX ade6-210 ura4-DS/E leu1-32
SPT429 Mat1-MsmtO leu-132 ade6-210 his2 ura4-DS/E mit1-13myc-
KanMX otr1R(SphI)::ura4
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ChIP. Chromatin immunoprecipitation (ChIP) analysis was per-
formed as previously described (47). Briefly, cells were grown at 32°C to
log phase and fixed in 1% formaldehyde for 15 min at room temperature.
Cells were lysed with a bead beater (Biospec Products) and sonicated
using a BioRuptor sonicating water bath (Diagenode) for 15 min (30-s
duty cycle). For immunoprecipitations, H3K9me2 (m5.1.1 [48]), H3K9ac
(Active Motif, catalog no. 39137), H3K14ac (Millipore, catalog no. 07-353),
Flag M2 (Sigma, catalog no. F1804), and c-Myc (Santa Cruz, catalog no.
9B11) antibodieswere incubatedovernightwith the lysate.Afterbeadwashes,
samples were treated with Chelex resin, followed by incubation with protei-
nase K. Samples were diluted and used in quantitative PCRs (qPCRs).
RNA analyses. Reverse transcription-PCR (RT-PCR) of centromeric
outer repeat transcripts and Northern analysis of centromeric siRNAs
were performed as previously described (47, 49, 50).
qPCRs. ChIP and RT-PCR samples were quantified by qPCRs carried
out with SYBR green on a LightCycler 480 instrument (Roche). The data
were analyzed using Light Cycler 480 software 1.5 (Roche). For ChIP,
enrichment was calculated as the ratio of target sequence to control se-
quence (act1) in the immunoprecipitated sample over input lysate. For
RT-PCR, quantification was relative to untreated dimethyl sulfoxide
(DMSO) control using act1/GAPDH as a negative region. Histograms
represent mean and standard deviation for three biological replicates.
Statistical significance was assessed by using the Student t test comparing
compound-treated strains with untreated strains of the same genotype or
mutant strains with the wild-type strain. Table 2 lists the primers used in
the present study.
Microarray analysis of gene expression. Total RNA was extracted
from S. pombe cells using the hot phenol method (51). RNA was purified
with an RNeasymini-kit (Qiagen) and tested for integrity on a 2200 Tape-
station (Agilent). 150 nanograms of RNA was used for labeling and array
hybridization using GeneChip S. pombe tiling 1.0FR microarrays accord-
ing to the GeneChip Whole Target labeling and hybridization protocol
(Affymetrix). The data were normalized with quantile normalization plus
scaling using Tiling Analysis Software (TAS) 1.1 and imported into the
Podbat browser program (52). Podbat was used to produce upregulated
gene lists for the different treatments using settings for various fold
changes and a P value of0.05. GeneSpring GX software (Agilent Tech-
nologies) was used to compare the gene lists obtained for compound
treatments with the gene lists for various S. pombemutants present in an
in-house database in the Ekwall laboratory. Cutoffs of 1.28 and 1.5 were
used for the HMSI-1 and HMSI-2 treatments, respectively, to recover a
comparable number of genes for both treatments. Biological duplicates
were prepared and analyzed for each condition.
Plant growth and histochemistry. The transgenic Arabidopsis thali-
ana L5 line has been described elsewhere (53). Seeds were surface steril-
ized and sown on MS agar plates with 15 g/liter sucrose. Plates were cold
treated for 2 days at 4°C. Seedlings were grown at 20°C under fluorescence
white light (fluence rate of 40 to 60 mol m2 s1) with a 16-h light/8-h
dark photoperiod. At 12 days postgermination, seedlings were transferred
to liquid MS in a 40-ml flask and, after 24 h, 10 M HMS-I1, 10 M
HMS-I2, or DMSOwas added. Compound treatment was repeated 3 days
later, and samples were collected 2 days later. 	-Glucuronidase (GUS)
staining was performed as previously described (54) with minor modifi-
cations. Plant tissueswere immersed in histochemicalGUS staining buffer
{100 mM NaPO4, 0.5 mM K3[Fe(CN)6], 0.5 mM K4[Fe(CN)6], 20%
methanol, 0.3% Triton X-100, and 1 mg/ml X-Gluc (5-bromo-4-chloro-
3-indolyl-	-D-glucuronic acid; pH 7)}, vacuum infiltrated under pressure
for 10 min three times, and then incubated overnight at 37°C. Samples
were washed several times with absolute ethanol until complete tissue
clarification, incubated for 24 h in water, and stored in 50% glycerol.
Images were taken using a Dotslide Olympus VS120.
Transcriptional silencing assay in MEL cells. Murine erythroleuke-
mia (MEL) suspension cells were grown in Dulbecco modified Eagle
medium (Gibco) with fetal bovine serum and penicillin-streptomycin
at 37°C in the presence of each compound or DMSO solvent control.
fluorescence-activated cell sorting (FACS) analysis of enhanced green
fluorescent protein (eGFP) expression was performed with a Becton
Dickinson FACS analyzer. For ChIP analysis, MEL cells were grown for
3 days in the presence of compounds and then fixed with 1% formal-
dehyde for 5 min at room temperature. Immunoprecipitated DNAwas
obtained with antibodies to H3K9me2 (Urano; Kimura 007) and
H3K9me3 (Abcam; Kimura 008). Quantitation of ChIP was per-
formed by qPCR as described above.
Recombinant Clr3 protein production. Using the MultiBac sys-
tem (55), Clr3 was expressed in Sf9 insect cells as an N-terminal fusion
of the codon optimized sequence to a multifunctional tag composed of
OneStrep-Sumostar (OSS) (56), T7 tag, and a TEV site. The OSS-Clr3
protein was purified on a StrepTrap column (GE Healthcare), cleaved
from the tag using tobacco etch virus (TEV) protease, and purified to
homogeneity by gel filtration on Superdex 200 (GE Healthcare) in 10
TABLE 2 Primers or probes used in this study
Primer or probe
Sequence (5=–3=)
Forward Reverse
qPCR primers
act1 CCCAAATCCAACCGTGAGAAGATG CCAGAGTCCAAGACGATACCAGTG
kanMX GGCCTGTTGAACAAGTCTG TCCGACTCGTCCAACATC
cen(dg) AATTGTGGTGGTGTGGTAATAC GGGTTCATCGTTTCCATTCAG
mat GTCCGAGGCAATACAACTTTGG GGTTGACAGTAGGAGATATTTACAG
tlh GGATAAGCCAATCATCGTTGAG GTAGTTGACGCTCCTTGGAAG
Pc CAGGTGCTTCAGCCAAATG GCTAATTGTGACCAGGCAAG
Pi CACTAAACCCCACTTGATGC CGCTGACAGGTCGTAAAACTC
Mc CCTGTTGGATGGGAATTCTG AAAAGCATTAGGGGGTCTCG
eGFP AGGGCTATGTGCAGGAGAGA GGGTGGACAGGTAATGGTTG
amylase TTCTGCTGCTTTCCCTCATT CGAACAGGTGGACAATAGCA
GAPDH ACCCAGAAGACTGTGGATGG CACATTGGGGGTAGGAACAC
HDAC6 TAAGGAAATGACCACACCGA CTGAGCAAGCACAGCCTTAG
HDAC10 TGGAGTGCTCCATCAAGAAG TCTTATCTGCCCATCCATGA
Northern probes
IK8 ATTCCTTTCTGAACCTCTCTGTTAT
IK9 TTTGATGCCCATGTTCATTCCACTTG
IK10 GGGAGTACATCATTCCTACTTCGATA
snR58 GATGAAATTCAGAAGTCTAGCATC
Castonguay et al.
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mM HEPES (pH 7.6), 200 mM KCl, 1 mM dithiothreitol, and 50 mM
magnesium acetate.
In vitro HDAC assays. Clr3 assays were performed with an HDAC
fluorometric assay kit from BioVision (K330-100) according to the man-
ufacturer’s instructions. Recombinant human HDAC assays were per-
formed by Reaction Biology (Malvern, PA). Compounds and purified
recombinant HDACs were preincubated 20 min in assay buffer (50 mM
Tris-HCl [pH 8.0], 137 mM NaCl, 2.7 mM KCl, and 1 mM MgCl2, 1
mg/ml bovine serum albumin, 1%DMSO), before the addition of 50M
fluorogenic substrate [Arg-His-Lys-Lys(Ac)-AMC]. Reaction mixtures
were incubated for 2 h at 30°C. The deacetylated substrate was then
cleaved by trypsin, which released the fluorescent 7-amino-4-methylcou-
marin. Fluorescent signals were read with an EnVision multilabel plate
reader (Perkin-Elmer).
siRNAknockdown ofHDAC6 andHDAC10 inMEL cells.Cells were
transfected with sense and antisense small interfering RNA (siRNA) at a
final concentration of 100 nM (HDAC6 sense, GGAGGAAGAUGA
AGUGGAAuu; HDAC10 sense, GGACAAGCCUCCAGCAAAAuu) with
DharmaFECT2 reagent. Cells were collected 48 h after transfection.
Scrambled siRNAs were included as controls. Statistical significance was
assessed by using the Student t test comparing HDAC6/10 siRNA with
scrambled siRNA treatments.
GEO accession number.All microarray data are available under GEO
accession number GSE57207.
RESULTS
Small-molecule inhibitors of fission yeast centromeric hetero-
chromatin integrity. To screen for inhibitors of fission yeast het-
FIG 1 HMS-I1 and HMS-I2 disrupt centromeric heterochromatin integrity in fission yeast. (A) Schematic diagram showing the position of the cen1
imr1R(NcoI):kanMX (cen1-kanMX for short) reporter gene in centromere 1 relative to the dg and dh outer repeat (otr) elements, the innermost repeats (imr) and
the central core (cnt). The position of heterochromatin and CENP-ACnp1 chromatin domains is indicated. Locations of primers used in panel E below are
indicated by the gray and black bars. cen(dg) primers amplify a sequence present in all centromeres. (B) Plating assay of the cen1-kanMX strain on YES plates with
10 g/ml G418 or without G418 (nonselective). (C) Growth curves of cen1-kanMX cells in YES media with 5 M HMS-I1, 5 M HMS-I2, and 10 mM
nicotinamide (Nic), with 10 g/ml G418 or without G418 (nonselective). (D) Chemical structures of HMS-I1 and HMS-I2. (E) qChIP analysis of H3K9me2
levels associated with the cen1-kanMX insertion or cen(dg) repeats, relative to act1. (F) qChIP analysis of H3K9ac and H3K14ac levels associated with the
cen1-kanMX insertion, relative to act1. In panels E and F, cells were grown in media containing 5 MHMS-I1 and 5 MHMS-I2, with 10 g/ml G418. Error
bars indicate standard deviations for three biological replicates. *, P 0.05; **, P 0.01; ***, P 0.0001.
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erochromatin integrity, we constructed a reporter strain harbor-
ing a dominant selectable kanamycin (kanMX) reporter gene
within the heterochromatin of centromere 1 (cen1). The kanMX
gene was inserted in the innermost repeats (imr) on the right side
of cen1 [cen1-imr1R(NcoI):kanMX, abbreviated as cen1-kanMX]
(Fig. 1A). Expression of kanMX normally confers resistance to
G418, but because in cen1-kanMX cells the reporter gene is si-
lenced by surrounding heterochromatin, these otherwise wild-
type cells exhibit sensitivity and grow poorly on plates containing
G418. Disruption of heterochromatin by deletion of the gene en-
coding Clr4methyltransferase (clr4
) allowed expression of cen1-
kanMX and resistance to G418 and thus increased growth on
G418 medium (Fig. 1B). Microwell-based liquid culture growth
assays, performed with or without G418 on cen1-kanMX cells,
enabled the reproducible detection of G418 resistance in clr4

cells compared to wild-type (wt) cells by continual monitoring of
optical density. Addition of the known Sirtuin HDAC inhibitor
nicotinamide also resulted in increased growth of wild-type cells
in the presence of G418 (Fig. 1C). This validated cen1-kanMX
reporter strain was subsequently used to screen 1,570 compounds
that had been previously selected for chemical diversity and bio-
activity (57). Two compounds, 2-(2,3-dihydro-1,4-benzo[b][1,4]
dioxin-6-yl)-6-methylimidazo[1,2-a]pyridine and N-(1-benzo-
[b]thiophen-2-yl)-4-(2-chloro-6-fluorobenzyl)piperazine-1-car-
boxamide, here referred to as HMS-I1 and HMS-I2, respectively
(heterochromatin-mediated silencing inhibitors 1 and 2), were
identified as reproducible hits that increased the resistance of
wild-type cen1-kanMX cells to G418 to a similar extent as nicoti-
namide (Fig. 1C and D).
To our knowledge, biological activity for HMS-I1 andHMS-I2
has not been reported previously. AlthoughHMS-I1 andHMS-I2
could conceivably fit into a commonpharmacophoremodel, their
structural disparities precluded straightforward conclusions. For
instance, the imidazopyridine and piperazine carboxamide cores
of HMS-I1 and HMS-I2, respectively, feature different numbers
and placement of hydrogen bond donors/acceptors, while their
lipophilic flanking groups differ in size and shape. HMS-I1 and
HMS-I2 lack compelling structural similarities to well-established
inhibitors of chromatin-modifying enzymes such asHDAC inhib-
itors (58, 59). We note that HMS-I1 and HMS-I2 do not contain
canonical zinc chelatingmoieties possessed by type I and IIHDAC
inhibitors: HMS-I1 cannot form a chelate due to a lack of heteroa-
toms disposed in a 1,4 relationship and the conceivable chelation
modes for HMS-I2 are electronically and sterically suboptimal.
Taken together, such structural considerations suggest that HMS-I1
andHMS-I2may be acting via a novel mechanism.
A hallmark of centromeric heterochromatin is the presence of
methylated histone H3K9 (H3K9me) chromatin over the centro-
meric repeats and inserted marker genes. Disruption of centro-
meric heterochromatin results in reduced levels of H3K9me and
loss of silencing of insertedmarker genes (28, 47, 60).Quantitative
ChIP (qChIP) analyses on cells grown under G418 selection re-
vealed that HMS-I1 and HMS-I2 caused substantial loss of
H3K9me2 from both the kanMX gene and the centromeric repeat
FIG2 HMS-I1 andHMS-I2 phenocopy loss of Clr3 or Sir2. (A) qChIP analysis ofH3K9me2 levels associatedwith the silentmat2-mat3 region of themating-type
locus (mat), relative to act1. Error bars indicate standard deviations from three biological replicates. (B) Quantification of mating-type gene transcripts (Pc, Pi,
andMc), relative to act1 transcript levels and normalized to relative levels in untreatedmat1
 cells. Error bars indicate standard deviations from two biological
replicates. (C) Northern blot analysis of enriched centromeric siRNAs. snoRNA58 (snR58) was used as a loading control. (D) Quantification of cen(dg) relative
to act1 transcript levels and normalized to relative levels in wild-type cells. Error bars indicate standard deviations for three biological replicates. *, P 0.05; **,
P 0.01; ***, P 0.0001. HMS-I1 and HMS-I2 were used at a concentration of 5 M in panels A to D. The media contained 10 g/ml G418 in panels A,
C, and D.
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elements (Fig. 1E). Importantly, the qChIP assay monitored
H3K9me2 associated with the 18 copies of otr/dg centromere re-
peats distributed over the three centromeres. HMS-I1 and
HMS-I2 thus altered the status of H3K9 methylation across all
three centromeres, demonstrating that the compounds affect het-
erochromatin throughout the nucleus and not just at the selected
cen1-kanMX locus. Neither compound induced a complete loss of
H3K9me2, as observed in cells lacking Clr4 H3K9 methyltrans-
ferase (clr4
) (Fig. 1E). Growth of cen1-kanMX cells in the pres-
ence of HMS-I1 or HMS-I2, but in the absence of G418 selection,
had less dramatic effects since the H3K9me2 levels were lower on
kanMX but not on the native outer repeat sequences (data not
shown and see Fig. 3).
Histone hypoacetylation is also a hallmark of heterochroma-
tin, and an increase in histone lysine acetylation is expected to
accompany the loss of centromeric marker gene silencing. Con-
sistently, we observed an increase inH3K9 andH3K14 acetylation
on cen1-kanMX in cells treated with HMS-I1 and HMS-I2 grown
in the presence of G418 (Fig. 1F). We conclude that HMS-I1 and
HMS-I2 increase the G418 resistance of cen1-kanMX cells by gen-
eral disruption of centromeric heterochromatin and concomitant
elevated expression of the embedded kanMX resistance gene.
HMS-I1 and HMS-I2 inhibit events downstream of RNAi in
chromatinmodification andheterochromatin formation.RNAi
is required for both the establishment and the maintenance of
centromeric heterochromatin in fission yeast (61–63). In contrast,
following RNAi-triggered establishment of heterochromatin do-
mains over themat2-mat3 region of the mating-type locus or adja-
cent to telomeres, RNAi is not continuously required to maintain
heterochromatin since alternative pathways propagate heterochro-
matin at these locations (64–67). ChIP analyses showed that, as ex-
pected, H3K9me2 was lost atmat2-mat3 and telomeres in cells that
lackedClr4H3K9methyltransferase, or theHDACsClr3 and Sir2,
but was retained in cells that lack RNAi due to deletion of Dcr1.
H3K9me2 levels were also consistently reduced at both mating-
type and subtelomeric regions when cen1-kanMX cells were incu-
bated with HMS-I1 or HMS-I2 and selected for G418 resistance
(Fig. 2A and data not shown).
FIG 3 Clr3 is a putative target of HMS-I1 and HMS-I2. qChIP analysis of H3K9me2 levels associated with centromeric repeats [cen(dg)], relative to act1. Cells
were grown in the presence of 5 M HMS-I1 or HMS-I2 and without G418 selection. Error bars indicate standard deviations for three biological replicates.
*, P 0.05; **, P 0.01; ***, P 0.0001.
FIG 4 HMS-I1 and HMS-I2 mimic the effect of SHREC mutations on gene
expression. (A) Overlap between gene sets upregulated in cells grown in the
presence of HMS-I1 andHMS-I2. (B) Expression profiles of cells grown in the
presence of HMS-I1 or HMS-I2 compared to the indicated SHREC mutants.
The P value (hypergeometric probabilities) of the overlap between gene lists is
indicated in cases where a statistical significance was observed. Genes upregu-
lated in cells that lack RNAi (ago1
 and dcr1
) or the Sir2 HDAC (sir2
) were
also compared but showed no significant overlap with those upregulated by
HMS-I1 and HMS-I2 treatment. *, data fromHansen et al. (69); **, data from
Wiren et al. (18); ***, data from the present study (see Data set S1 in the
supplemental material). Cells were grown in YESmediumwith 5MHMS-I1
or HMS-I2 and 10 g/ml G418 in panels A and B. Comparisons in panels A
and B are restricted to annotated genes present in the Ekwall laboratory in-
house database.
Compounds That Disrupt Heterochromatin Integrity
February 2015 Volume 35 Number 4 mcb.asm.org 667Molecular and Cellular Biology
 o
n
 M
arch 2, 2015 by UNIVERSITY O
F EDINBURG
H
http://m
cb.asm
.org/
D
ow
nloaded from
 
Heterochromatin-mediated silencing at the mating-type locus
ensures that the silent mating-type cassettes encoding plus (P) or
minus (M) information (mat2-P and mat3-M) cannot be ex-
pressed. These cassettes must normally be recombined into the
active mat1 expression site to escape the powerful repressive het-
erochromatin environment of the silent loci and allow expression.
Mutations in CLRC (Clr4-Rik1-Cul4) complex and HDAC com-
ponents are known to alleviate transcriptional silencing at the
mat2-P and mat3-M loci (26). Strikingly, treatment of a sterile
fission yeast strain lacking the mat1 expression site (i.e., a mat1

strain that lacks the kanMX reporter gene) with HMS-I1 and
HMS-I2 resulted in the expression of Pc/Pi and Mc transcripts
from the silent mat2-P and mat3-M cassettes, respectively (Fig.
2B). Thus, similar to the deletion of HDAC and CLRC compo-
nents, HMS-I1 and HMS-I2 disrupt the robust form of hetero-
chromatin-mediated silencing that normally ensures thatmat2-P
or mat3-M are not transcribed. From these results we concluded
that both HMS-I1 and HMS-I2 must interfere with heterochro-
matin formation downstream of RNAi.
In cells with defective RNAi or Clr4, noncoding outer repeat
transcripts accumulate as they are no longer processed by RNAi to
siRNA and transcriptional silencing is reduced. In contrast, cells
that lack either Clr3 or Sir2 exhibit reduced H3K9 methylation
levels on centromeric repeats but retain high siRNA levels with
only a slight increase in centromeric transcripts (15, 16, 62). These
phenotypic differences allow the mechanism of action of specific
mutants or inhibitors to be distinguished. Despite the reduced
levels of H3K9me2 detected on centromere repeats in wild-type
cells grown in the presence ofHMS-I1 orHMS-I2 andG418, these
cells retained high levels of centromeric siRNA, while centromeric
repeat transcripts remained low (Fig. 2C and D). Hence, HMS-I1
or HMS-I2 treated cells resemble clr3
 and sir2
 cells. These re-
sults demonstrate that HMS-I1 and HMS-I2 phenocopy the loss
of Clr3 and Sir2 and suggest that both compoundsmight interfere
with either Clr3- or Sir2-related functions.
The Clr3 HDAC is a putative target of HMS-I1 and HMS-I2.
Epistasis analysis has shown that RNAi operates in a parallel path-
way to the HDACs Clr3 and Sir2 to maintain heterochromatin
integrity at centromeres (61, 62, 68). Cells devoid of an RNAi
component such as Dcr1, or either the Clr3 or Sir2 HDACs, retain
significant levels of H3K9me on centromeric repeats. However,
the removal of both Dcr1 and Clr3 or Sir2 reduces H3K9me to
much lower levels than that observed in dcr1
, clr3
 or sir2
 cells
alone (62, 68). To determine whetherHMS-I1 andHMS-I2might
exacerbate the phenotype of cells lacking Dcr1, Clr3 or Sir2, we
compared the levels of H3K9me2 on centromeric repeats in wild-
type, dcr1
, clr3
, or sir2
 cells grown in the presence or absence
of either compound, all in the absence of G418 selection. HMS-I1
and HMS-I2 exhibited strong chemical-genetic interactions with
dcr1
 and sir2
, since a greater reduction in the level ofH3K9me2
associated with centromeric repeats was observed in the presence
of each compound but not with clr3
 (Fig. 3). HMS-I1 and
HMS-I2 therefore behaved as chemical mimetics of the clr3
mu-
tation in terms of interactions with either dcr1
 or sir2
 (62, 68).
These chemical-genetic interactions, coupled with the observa-
tion that neither compound further reduced H3K9me2 levels on
centromere repeats in clr3
 cells, imply that both HMS-I1 and
FIG 5 HMS-I1 and HMS-I2 inhibit Clr3 HDAC activity in vitro without affecting recruitment of SHREC at heterochromatin. (A and B) qChIP analysis of Clr3
(Clr3-3XFLAG) (A) and Mit1 (Mit1-13xmyc) (B) recruitment at centromeric repeats [cen(dg)] and at the silent mat2-mat3 region of the mating-type locus
(mat), relative to act1. Cells were grown in the presence of 5 MHMS-I1 or HMS-I2. Error bars indicate the standard deviations of three biological replicates.
*, P 0.05; **, P 0.01; ***, P 0.0001. (C andD) Fluorescence-based deacetylation assays were used to detect inhibition of recombinant S. pombeClr3HDAC
activity in vitro at the indicated concentrations of HMS-I1 (C) and HMS-I2 (D). Error bars indicate standard deviations for three replicates.
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HMS-I2 interfere with the function of either the HDAC Clr3
and/or associated proteins in the SHREC complex.
HMS-I1 and HMS-I2 mimic the effect of SHREC mutations
on gene expression. Previous genome-wide expression profiles
showed that the Clr3 HDAC is required to repress expression of a
broad cohort of genes (183 genes 1.5-fold upregulated in clr3-
735 [69]). Clr3 has been shown to associate with Clr1, Clr2, and
Mit1 within the repressive SHREC complex, and all four compo-
nents contribute to heterochromatin integrity (15). If HMS-I1
and HMS-I2 interfere with Clr3 or SHREC function as predicted,
then each compound should cause induction of a gene set that
overlaps with that upregulated in SHREC mutant cells. In cells
grown in the presence of compounds and G418, HMS-I1 and
HMS-I2 increased the expression of 37 and 200 genes by 1.5-
fold, respectively. Significant overlap was evident between the sets
of genes affected by HMS-I1 and HMS-I2: 36 of the 37 genes
upregulated 1.5-fold byHMS-I1were also upregulated 1.5-fold by
HMS-I2 (P 3.28 1053) and 131 of the 200 genes upregulated
1.28-fold by HMS-I1 were also upregulated 1.5-fold by HMS-I2
(P 1.09 10175) (Fig. 4A; see Data set S1 in the supplemental
material). Compared to expression profiles for clr1-5, clr2
, clr3-
735, andmit1
 strains (69) (see alsoData set S1 in the supplemen-
tal material), we observed significant overlap between genes dere-
pressed in the SHREC mutants and HMS-I1 or HMS-I2 treated
cells (Fig. 4B). No significant overlap was detected when we com-
pared genes upregulated by HMS-I1 or HMS-I2 with those in-
creased in cells that lackRNAi components (ago1
 and dcr1
; Fig.
4B). Previous analyses showed that Clr3 and Sir2 mediate the re-
pression of an overlapping set of genes (18), which explains the
few genes whose expression increases after exposure toHMS-I1 or
HMS-I2 and that are also upregulated in sir2
 cells (Fig. 4B).
However, the overlap between genes upregulated by HMS-I1 and
HMS-I2 and those upregulated in sir2
 cells is not significant.
Based on this analysis of global gene expression, we conclude that
the SHREC complex is a likely target for the inhibitory activity of
both HMS-I1 and HMS-I2.
HMS-I1 and HMS-I2 reduce in vitro Clr3 HDAC activity.
The genetic analyses described above indicate that HMS-I1 and
HMS-I2 impede the activity of the fission yeast SHREC complex,
which contains the type II HDAC Clr3. We first assessed whether
HMS-I1 and HMS-I2 acted by preventing the recruitment of
SHREC components at heterochromatin. ChIP analyses showed
that neither HMS-I1 nor HMS-I2 affected the recruitment of ei-
ther the Clr3 HDAC or the Mit1 chromatin remodeling compo-
nents of SHREC to mating-type or centromeric heterochromatin
(Fig. 5A and B). To determine whether these compounds exert
their effect on SHREC function through inhibition of Clr3 cata-
lytic activity, we performed in vitro fluorescence-based HDAC
assays. HMS-I1 and HMS-I2 reproducibly reduced the activity of
Clr3 by 40 and 80%, respectively (Fig. 5C and D). Under these
assay conditions, HMS-I2 inhibits Clr3 to a greater extent than
HMS-I1, a finding consistent with the greater reduction in H3K9
methylation observed in HMS-I2-treated sir2
 and dcr1
 cells
and the greater increase in gene expression caused byHMS-I2 (see
Fig. 3 and 4). Collectively, these data suggest that HMS-I1 and
HMS-I2 are inhibitors of Clr3 HDAC activity.
HMS-I1andHMS-I2disrupt transgene silencing inmulticel-
lular eukaryotes. To assess whether HMS-I1 and HMS-I2 might
also disrupt heterochromatin integrity in multicellular eukaryotes,
we tested for the effects on gene silencing in plants and mamma-
lian cells. We first tested whether HMS-I1 and HMS-I2 could al-
leviate reporter gene silencing in theArabidopsis thalianaL5 trans-
genic line, which contains a transcriptionally silenced GUS
transgene (53). HMS-I1 caused an increase in the GUS reporter
FIG 6 HMS-I1 and HMS-I2 alleviate transcriptional silencing of a GUS transgene in Arabidopsis L5 seedlings. (A) Histochemical staining of A. thaliana L5
transgenic seedlings for 	-glucuronidase (GUS) activity after incubation with 10 M HMS-I1, 10 M HMS-I2, or solvent control. (B) Magnified view of root
tissue. (C) Magnified view of leaf tissue.
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expression in the root and leaf tissue, whereas HMS-I2 alleviated
silencing in the leaf tissue only (Fig. 6). Transcriptional gene si-
lencing mutants reactivate the expression of GUS, whereas RNAi
mutants do not (70), indicating that, as in fission yeast, HMS-I1
and HMS-I2 mediate their effects in Arabidopsis independently of
RNAi.
We next assessed the effect of the compounds on reporter gene
silencing in MEL cells. A 	-globin gene promoter-driven eGFP
reporter is known to be silenced and coated in repressive H3K9
methylated chromatin at the RL5 locus in these MEL cells when
vector backbone bacterial DNA is inserted upstream of the trans-
gene (designated RL5/pYB) (Fig. 7A) (71). In addition, the inclu-
sion of an array of human -satellite repeats upstream of the
reporter (designated RL5/pYB-Sat) (Fig. 7A) bolsters eGFP
silencing and H3K9me levels across the transgene (71). We uti-
lized both RL5/pYB and RL5/pYB-Sat MEL cell lines to deter-
mine whether HMS-I1 or HMS-I2 interfere with the integrity of
heterochromatin at the reporter locus. FACS analysis of the RL5/
pYB and RL5/pYB-Sat cell lines showed that eGFP expression
increased over time with HMS-I1 but not with HMS-I2 (Fig. 7B).
Thus, growth in the presence of HMS-I1 overcomes the strong
silencing mediated by -satellite repeats in MEL cells.
To determine whether HMS-I1 also alters H3K9 methylation
levels associatedwith silent transgenes inmulticellular eukaryotes,
we performed ChIP analysis with the RL5/pYB-Sat cell line, for
which the observed effect on silencing was the strongest. A sub-
stantial decrease in both H3K9me2 and H3K9me3 levels associ-
ated with the eGFP reporter occurred after 3 days of incubation
withHMS-I1. Furthermore, a reduction inH3K9methylationwas
also detected on the endogenous mouse amylase gene (Fig. 7C)
that is normally repressed in MEL cells (72). Thus, HMS-I1 can
disrupt heterochromatin associated with endogenous repressed
genes, in addition to that formed by mammalian repetitive ele-
ments over the 	-globin/eGFP reporter.
In S. pombe, our data suggested that the type II HDACClr3 is a
target of HMS-I1. Although the identity of HMS-I1 target(s) in
mammalian cells remains to be defined in vivo, an in vitroHDAC
assay performed with a panel of human recombinant enzymes
indicated thatHMS-I1 reduced the activity of the type IIbHDACs,
HDAC6 and HDAC10 (Fig. 8A). Consistent with inhibition of
these HDACs, siRNA knockdown of either HDAC6 or HDAC10
expression resulted in increased 	-globin–eGFP transcript levels
in both RL5/pYB and RL5/pYB-Sat MEL cell lines compared to
scrambled siRNA controls (Fig. 8B and C). Collectively, these re-
sults suggest that HMS-I1, and possibly also HMS-I2, derepress
transcriptionally silent heterochromatin in evolutionarily distant
species through inhibition of conserved HDACs.
DISCUSSION
Heterochromatin is tightly associated with transcriptional silenc-
ing inmost eukaryotes and is particularly prevalent over repetitive
elements, where it prevents inappropriate recombination events
and genome rearrangements (3). The aberrant silencing of genes
through unscheduled heterochromatin formation is known to
contribute to several human diseases, including acute myeloid
leukemia and Friedreich’s ataxia (73, 74). Moreover, the manipu-
lation of transcriptional silencing has been used to improve crop-
plant produce and yields (75). Since RNAi-related mechanisms
establish sequence-specific heterochromatin in many eukaryotes,
we exploited thewell-understood process of heterochromatin for-
mation in fission yeast to develop a novel screen for small-mole-
cule modulators of heterochromatin integrity. Collectively, our
analyses indicate that HMS-I2 alleviates heterochromatin-medi-
ated gene silencing in both fungal and plant systems but not MEL
cells, whereasHMS-I1 abrogates silencing across the fungal, plant,
and animal kingdoms. Both HMS-I1 and HMS-I2 were observed
to inhibit the in vitro activity of fission yeast class II Clr3 HDAC,
FIG 7 HMS-I1 disrupts heterochromatin mediated transcriptional silencing
in murine erythroleukemia (MEL) cells. (A) Schematic diagram of the 	-glo-
bin/eGFP reporter inserted with (MEL RL5/pYB-Sat) or without (MEL RL5/
pYB) adjacent -satellite arrays at the RL5 locus in MEL cells (71). (B) FACS
analysis tomonitor eGFP expression by fluorescence of RL5/pYB or RL5/pYB-
Sat MEL cells. Fluorescence was normalized relative to untreated DMSO
controls, after consecutive days of growth in medium containing 10 M
HMS-I1 or 10 M HMS-I2. Error bars indicate the standard deviations from
three biological replicates. (C) qChIP analysis of H3K9me2 and H3K9me3
levels associatedwith theRL5/pYB-Sat	-globin–eGFP reporter gene and the
endogenous mouse amylase gene after 3 days incubation with or without 10
MHMS-I1. Error bars indicate standard deviations for three biological rep-
licates. *, P 0.05; **, P 0.01; ***, P 0.0001.
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whereas only HMS-I1 inhibited the human subclass IIb enzymes,
HDAC6 and HDAC10. Phylogenetic analysis indicates that hu-
man HDAC6 and HDAC10 are closely related to Clr3 (76), with a
similar domain architecture of the HDAC catalytic domain fol-
lowed by a conserved C-terminal domain. Although the major
substrate of HDAC6 has been reported to be acetylated -tubulin
(77), this enzyme has also been implicated in chromatin regula-
tion and could play a direct role in histone deacetylation (78).
HDAC10 possesses HDAC activity and has been implicated in
autophagy and cancer (79, 80). Therefore, our cross-species com-
parisons suggest that type II HDAC enzymes may be conserved
targets of HMS-I1 and potentially also HMS-I2.
Inspection of the chemical structure of HMS-I1 and HMS-I2
suggests that theirmechanism of action is likely to differ from that
of canonical HDAC inhibitors, particularly as neither HMS-I1 or
HMS-I2 have obvious zinc-chelating characteristics. HMS-I1 and
HMS-I2may therefore represent a novel class of HDAC inhibitor.
We note that while in vitro HDAC inhibition assays suggest that
FIG 8 HMS-I1 reduces the activity of mammalian HDAC6 and HDAC10 in vitro. (A) Fluorescence-based deacetylation assays were used to detect inhibition of
recombinant human HDAC6 and HDAC10 activity in vitro at the indicated concentrations of HMS-I1. Error bars indicate the standard deviations from two
replicates. (B) Quantification of eGFP transcripts relative to GAPDH (glyceraldehyde-3-phosphate dehydrogenase) transcript levels after siRNA knockdown of
HDAC6 and HDAC10 in MEL cells with a 	-globin/eGFP reporter inserted with (RL5/pYB-Sat) or without (RL5/pYB) adjacent -satellite arrays at the RL5
locus. Error bars indicate the standard deviations from three biological replicates. (C) Quantification of HDAC6 and HDAC10 transcripts relative to GAPDH
transcript levels after siRNA knockdown of HDAC6 and HDAC10 in RL5/pYB and RL5/pYB-Sat MEL cells. Error bars indicate standard deviations for three
biological replicates. *, P 0.05.
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HMS-I1 and HMS-I2 directly target HDAC activity, it remains
formally possible that these compounds also affect heterochroma-
tin integrity in vivo by interfering with other activities and/or pro-
tein interactions within HDAC complexes. A detailed structure-
activity relationship (SAR) analysis will be required to improve
potency and further delineate the mechanism of HMS-I1 and
HMS-I2 action. Regardless, our discovery ofHMS-I1 andHMS-I2
as panspecies inhibitors of heterochromatin-mediated transcrip-
tional gene silencing demonstrates the striking functional conser-
vation of the silencing machinery through eukaryotic evolution.
HMS-I1 and HMS-I2 should serve as new chemical probes for
dissection of silencing functions in various species and represent
possible candidates for early stage drug development in diseases
that result from inappropriate gene silencing events.
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